Retrograde intrarenal surgery cost-effective option for managing 1-2 cm renal stones
Management of renal stones has been under research. For 1-2cm renal stones, retrograde intrarenal surgery (RIRS) is most cost-effective, finds a study.
The research is published in the Urology Journal.
Kevin M. Wymer and colleagues from the Department of Urology, Mayo Clinic, Rochester, conducted the recent study to perform a cost-effectiveness evaluation comparing the management options for mid-size (1-2cm) renal stones including percutaneous nephrolithotomy (PCNL), retrograde intrarenal surgery (RIRS), and shockwave lithotripsy (SWL).
The authors created a Markov model to compare cost-effectiveness of percutaneous nephrolithotomy, mini- percutaneous nephrolithotomy, retrograde intrarenal surgery, and shockwave lithotripsy for 1-2cm lower pole (index patient 1) and percutaneous nephrolithotomy, retrograde intrarenal surgery, and shockwave lithotripsy for 1-2 cm non–lower pole (index patient 2) renal stones.
A literature review provided stone free, complication, retreatment, secondary procedure rates, and quality adjusted life years (QALYs). Medicare costs were used. The incremental cost-effectiveness ratio (ICER) was compared with a willingness-to-pay(WTP) threshold. One-way and probabilistic sensitivity analyses were performed.
Disclaimer: This website is primarily for healthcare professionals. The content here does not replace medical advice and should not be used as medical, diagnostic, endorsement, treatment, or prescription advice. Medical science evolves rapidly, and we strive to keep our information current. If you find any discrepancies, please contact us at corrections@medicaldialogues.in. Read our Correction Policy here. Nothing here should be used as a substitute for medical advice, diagnosis, or treatment. We do not endorse any healthcare advice that contradicts a physician's guidance. Use of this site is subject to our Terms of Use, Privacy Policy, and Advertisement Policy. For more details, read our Full Disclaimer here.
NOTE: Join us in combating medical misinformation. If you encounter a questionable health, medical, or medical education claim, email us at factcheck@medicaldialogues.in for evaluation.